Argo Biopharma to present updated BW-20805 Phase II results at EAACI 2026 Congress
Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma
Sanofi secures EU approval for subcutaneous Sarclisa with on-body injector
Sciwind Biosciences reports positive study data on ecnoglutide versus semaglutide
OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance
Owkin to build AI agents as part of K Pro collaboration with Sanofi
Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline
Kexing Biopharm begins enrolment for Phase I trial of GB10 in China
Lupeng Pharmaceutical's rocbrutinib receives Chinese approval to treat R/R mantle cell lymphoma
Pharming secures FDA acceptance of Joenja filing for children with APDS
UCB and Biogen present Phase 3 data highlighting potential of dapirolizumab pegol in lupus treatment
Persist AI partners with Microsize and Micromacinazione to launch drug formulation platform
RedHill Biopharma advancing opaganib options for Ebola outbreak